Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 2/20 | 0.67 |
| ▸ | RAB9A | P51151 | 2/20 | 0.67 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.67 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.57 |
| ▸ | GAA | P10253 | 2/20 | 0.55 |
| ▸ | GPR139 | Q6DWJ6 | 1/20 | 0.50 |
| ▸ | TACR1 | P25103 | 1/20 | 0.48 |
| ▸ | GBA1 | P04062 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | POLB | P06746 | 2/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | BCAT2 | O15382 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | SLC6A9 | P48067 | 1/20 | 0.46 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4982059 | 1.00 | NPC1 (0.67) | NPC1RAB9ASMN1; SMN2EPHX2GAA | |
| Hydrochloric Acid SCHEMBL5405392 | 0.98 | NPC1 (0.65) | NPC1RAB9ASMN1; SMN2EPHX2GAA | |
| Hydrochloric Acid SCHEMBL5399781 | 0.88 | LMNA (0.58) | NPC1RAB9ASMN1; SMN2EPHX2KMT2A | |
| SCHEMBL21523087 | 0.85 | EPHX2 (0.65) | NPC1RAB9ASMN1; SMN2EPHX2KMT2A | |
| SCHEMBL21523088 | 0.85 | EPHX2 (0.65) | NPC1RAB9ASMN1; SMN2EPHX2KMT2A | |
| SCHEMBL31530566 | 0.83 | NPC1 (0.73) | NPC1RAB9ASMN1; SMN2EPHX2GAA | |
| SCHEMBL14861144 | 0.83 | GBA1 (0.51) | NPC1RAB9ASMN1; SMN2GBA1BCAT2 | |
| SCHEMBL1206387 | 0.83 | GBA1 (0.51) | NPC1RAB9ASMN1; SMN2GBA1BCAT2 | |
| SCHEMBL14861146 | 0.83 | GBA1 (0.51) | NPC1RAB9ASMN1; SMN2GBA1BCAT2 | |
| SCHEMBL28212893 | 0.83 | NPC1 (0.62) | NPC1RAB9ASMN1; SMN2EPHX2GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190330141-A1 | Compositions With A Cooling Effect | THE PROCTER & GAMBLE COMPANY | 2019-10-31 | — | — | US | disclosed |
| US-20190330141-A1 | Compositions With A Cooling Effect | THE PROCTER & GAMBLE COMPANY | 2019-10-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190330141-A1 | Compositions With A Cooling Effect | CUTA, FABP4, EBP | NPC1 2946/4885RAB9A 2546/4885SMN1; SMN2 1308/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.